📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Voyageur Pharmaceuticals

1.1 - Company Overview

Voyageur Pharmaceuticals Logo

Voyageur Pharmaceuticals

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of mining-based pharmaceutical products and imaging contrast agents for medical radiology, producing barite and iodine APIs for barium contrast applications (x-radiation, CT, MRI), including SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD GI barium suspensions/powders, and V-Gas, an under-development antacid/antiflatulent for double contrast studies.

Products and services

  • SmoothHD: Radiology-grade high-density barium suspension for upper GI esophagogram and double-contrast studies of the gastrointestinal tract and colon
  • SmoothLD: Clinical-grade low-density barium suspension product for single-contrast radiographic examinations of the esophagus, stomach, and small bowel
  • SmoothX: Medical-grade contrast medium for Computed Tomography (CT) of the gastrointestinal tract, supporting high-quality imaging with reproducible results.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Voyageur Pharmaceuticals

Qualicaps Logo

Qualicaps

HQ: United States Website
  • Description: Provider of two-piece empty pharmaceutical capsules and processing equipment, including gelatin capsules for oral dosage forms and dry powder inhalers; plant-based hypromellose capsules suited to moisture-sensitive APIs; inhalation capsules with superior aerosolization; and capsule filling, band-sealing, and visual inspection machines for precision, integrity, and quality control.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Qualicaps company profile →
WuXi Advanced Therapies Logo

WuXi Advanced Therapies

HQ: United States Website
  • Description: Provider of CDMO and integrated laboratory testing services to accelerate bio-based drugs, including TESSA scalable AAV vector production; XOFLX packaging and producer cell lines for lentiviral vectors; process development, IND-enabling studies, and phase-appropriate clinical manufacturing; plus comprehensive testing (viral clearance, biosafety, release, cell banking, stability) for cell and gene therapies, monoclonal antibodies, and vaccines.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full WuXi Advanced Therapies company profile →
Absolute Antibody Logo

Absolute Antibody

HQ: United Kingdom Website
  • Description: Provider of engineered and recombinant antibodies and related services for research and diagnostics, using a proprietary transient-transfection manufacturing platform to produce sequenced and engineered antibodies (AbsoluteAbs). Offerings include antibody sequencing, engineering and expression, primary antibodies, and recombinant antibodies against allergens, coronaviruses (including SARS-CoV-2), viruses, and DNA/RNA targets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Absolute Antibody company profile →
PolyPeptide Logo

PolyPeptide

HQ: Switzerland Website
  • Description: Provider of contract manufacturing for peptides and peptide-related molecules with a global presence ensuring reliable supply. One of the world's largest independent contract manufacturers of therapeutic peptides, offering peptide and oligonucleotide API development and manufacturing, generic and cosmetic peptides, and green chemistry initiatives, including a production-scale solvent recovery system with Donaldson Company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PolyPeptide company profile →
Vectura Logo

Vectura

HQ: United Kingdom Website
  • Description: Provider of inhalation drug delivery services; formulation development for inhalers, nebulisers, and nasal sprays; comprehensive pharmaceutical analysis; in-house manufacturing of drug products and medical devices for development studies and clinical trials; device platforms for DPI, pMDI, and nebuliser technologies; and process development and technical transfer for airways-related diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vectura company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Voyageur Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Voyageur Pharmaceuticals

2.2 - Growth funds investing in similar companies to Voyageur Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Voyageur Pharmaceuticals

4.2 - Public trading comparable groups for Voyageur Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Voyageur Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Voyageur Pharmaceuticals

What does Voyageur Pharmaceuticals do?

Voyageur Pharmaceuticals is a provider of mining-based pharmaceutical products and imaging contrast agents for medical radiology, producing barite and iodine APIs for barium contrast applications (x-radiation, CT, MRI), including SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD GI barium suspensions/powders, and V-Gas, an under-development antacid/antiflatulent for double contrast studies.

Who are Voyageur Pharmaceuticals's competitors?

Voyageur Pharmaceuticals's competitors and similar companies include Qualicaps, WuXi Advanced Therapies, Absolute Antibody, PolyPeptide, and Vectura.

Where is Voyageur Pharmaceuticals headquartered?

Voyageur Pharmaceuticals is headquartered in Canada.

How many employees does Voyageur Pharmaceuticals have?

Voyageur Pharmaceuticals has 1,000 employees 🔒.

When was Voyageur Pharmaceuticals founded?

Voyageur Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Voyageur Pharmaceuticals in?

Voyageur Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Voyageur Pharmaceuticals

Who are the top strategic acquirers in Voyageur Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Voyageur Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Voyageur Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Voyageur Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Voyageur Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Voyageur Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Voyageur Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Voyageur Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Voyageur Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Voyageur Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Voyageur Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Voyageur Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Voyageur Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Voyageur Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Voyageur Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Voyageur Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Voyageur Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Voyageur Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Voyageur Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Voyageur Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Voyageur Pharmaceuticals

Launch login modal Launch register modal